INTRODUCTION
Intestinal crypts contain stem cells and their transit-amplifying (TA) daughter cells. Cells exiting the proliferative crypts onto the villi terminally differentiate into enterocytes, goblet cells and enteroendocrine cells. Paneth cells escape the crypt-villus flow by migrating to crypt bottoms where they live for several weeks. With the exception of stem cells and Paneth cells, the intestinal epithelium is renewed approximately every 5 days (Barker et al., 2008) . Proliferation of epithelial crypt cells is Wnt-dependent. Mice that are mutant for an intestine-specific member of the Tcf transcription factor family, Tcf4/Tcf7l2, fail to establish proliferative crypts during late gestation (Korinek et al., 1998) , while conditional deletion of b-catenin Fevr et al., 2007) as well as transgenic expression of the secreted Dickkopf-1 Wnt inhibitor (Pinto et al., 2003; Kuhnert et al., 2004) leads to disappearance of proliferative crypts in adult mice. Moreover, malignant transformation of intestinal epithelium is almost invariably initiated by activating Wnt pathway mutations Morin et al., 1997) .
Because of the intimate connection between Wnt signaling and intestinal biology, we have attempted to unravel the TCF4 target gene program activated by this pathway in crypts and colorectal tumors (van de Wetering et al., 2002; van Es et al., 2005; van der Flier et al., 2007) . Using Cre-mediated genetic tracing, we demonstrated that Lgr5 marks long-lived, multipotent stem cells (Barker et al., 2007) , as predicted originally by Leblond and colleagues Leblond, 1974a, 1974b; Bjerknes and Cheng, 1981a , 1981b , 1999 . Each crypt bottom harbours around six of these small, cycling cells intermingled with Paneth cells. Although Lgr5 stem cells occasionally occupy a position directly above the Paneth cells, they are distinct from another proposed stem cell population located at the so called +4 position (Potten et al., 1974 (Potten et al., , 1977 , since Lgr5 stem cells are not particularly radiation-sensitive and do not retain DNA labels (Barker et al., 2007 (Barker et al., , 2008 . Bmi1 expression reportedly also marks cells at position +4. Lineage tracing has revealed that Bmi1 + cells mark pluripotent stem cells that replenish the epithelium with similar kinetics to Lgr5 stem cells (Sangiorgi and Capecchi, 2008 ). Bmi1 and Lgr5 stem cells may be distinct or may represent overlapping or even identical stem cell populations. Here, we identify the Ascl2 gene as one of a few Lgr5 stem cellenriched genes that were not detected in the immediate daughters. Ascl2 (Mash2/HASH2) is homologous to the Drosophila Achaete-scute complex genes (Johnson et al., 1990) . Ascl2 expression in the intestinal epithelium is Wnt-dependent Jubb et al., 2006; van der Flier et al., 2007) . The Ascl2 gene encodes a basic helix-loop-helix (bHLH) transcription factor with an unusually restricted expression pattern, i.e. its expression is predominantly detected in extraembryonic tissues (Guillemot et al., 1994) and in intestinal epithelium (see below). Ascl2 À/À embryos die from placental failure around 10.5 days post-coitum, when the spongiotrophoblasts lineage is depleted and the number of giant cells is elevated (Guillemot et al., 1994 ). Here we demonstrate an essential role for Ascl2 in the maintenance of adult intestinal stem cells.
RESULTS

Intestinal Stem Cell Transcriptome
We sorted GFP-positive epithelial cells from isolated crypts of Lgr5-EGFP-ires-CreERT2 mice (see Experimental Procedures). FACS analysis distinguished a GFP-high (GFP hi ) and a GFPlow (GFP lo ) population ( Figure 1A ), which we tentatively identified as Lgr5 stem cells and their immediate transit-amplifying daughters, respectively. A single mouse intestine routinely yielded several hundred thousand GFP hi and GFP lo cells. mRNA samples were subjected to comparative gene expression profiling. A comprehensive list of Lgr5 stem cell genes is given in Table S1 (available with this article online). The gene that was most highly enriched in the GFP hi cells was, satisfactorily, the Lgr5 gene itself. Multiple genes on the list were already identified as intestinal Wnt target genes previously (van der Flier et al., 2007) (Table S1 ). While in situ hybridizations on these Wnt target genes typically confirmed high level expression in Lgr5 stem B C D cells, TA cells directly above the Paneth cells often also expressed these genes, albeit at a lower level.
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As an example, Figure 1B shows the expression of Sox9, a Wnt-responsive gene (Blache et al., 2004) crucial for Paneth cell specification (Bastide et al., 2007; Mori-Akiyama et al., 2007) . Ascl2 was one of the known Wnt target genes Jubb et al., 2006; van der Flier et al., 2007) and was expressed in adenomas as expected (Figures S1A, S1D, and S1E). Its physiological expression, however, was restricted to cells at the base of crypts as revealed by in situ hybridization ( Figure 1C) . In situ hybridization analysis also identified Olfactomedin-4 (Olfm4) as a highlyspecific and robust marker for Lgr5 stem cells ( Figure 1D ). Olfm4 was not expressed under the control of Wnt, since it was absent from adenomas ( Figure S1B ). Human OLFM4 is enriched in human colon crypts (Kosinski et al., 2007) . OLFM4 is a secreted molecule originally cloned from human myeloblasts (Zhang et al., 2002) . Recently, it was shown that Xenopus ONT1, an Olfm family member, acts as a BMP antagonist (Inomata et al., 2008) .
To study the expression pattern of Ascl2 more precisely we generated monoclonal antibodies against the C-terminal part of the mouse Ascl2 protein. The mouse Ascl2 protein was detected in E10.5 spongiotrophoblasts cell nuclei by immunohistochemistry (IHC) ( Figure S1C ). In the intestine, Ascl2 was found to be expressed in slender cells with the unique morphology and location of Lgr5 stem cells ( Figure 1E ), yet was not expressed in Paneth cells or the transit-amplifying cells. Figure 1F compares Ascl2 nuclear staining to cytoplasmic GFP in Lgr5-EGFP-ires-CreERT2 knock-in intestine. Ascl2 was expressed by the Lgr5 stem cells at the crypt base as revealed by serial sectioning (Figures S1F and S1G) . GFP hi and GFP lo cells from duodenum, ileum and colon of Lgr5-EGFP-ires-CreERT2 mice were subjected to real-time qPCR analysis. This confirmed that Lgr5, Ascl2, Tnfrsf19 and Olfm4 were highly enriched in stem cells of the small intestine ( Figure S1H ). Only Lgr5 and Ascl2 were enriched in the GFP hi stem cells of the colon. Expression of Bmi1, another putative stem cell marker, was readily detected in all fractions and was slightly enriched in GFP hi stem cells of the small intestine, albeit to a lesser extent than Lgr5 or Ascl2. We then tested intestines from 4 week-old Bmi1 null animals (van der Lugt et al., 1994) for stem cell marker gene expression. Histologically and by marker analysis, the intestinal epithelium of these mutant mice was indistinguishable from wild-type littermates (van Lohuizen and Clevers, unpublished) . Both, Ascl2 and Olfm4 were expressed in the intestines of these animals (Figures S1I and S1J 
Transgenic Expression of Ascl2
We generated transgenic mice expressing a mouse Ascl2 cDNA under the control of the villin promoter (insert in Figure 2B ). This promoter drives expression throughout the intestinal epithelium and becomes fully active during late gestation (Pinto et al., 1999) . Four independent transgenic mice were born. Three of these showed growth retardation and were sacrificed within 2-3 weeks postnatally. The founder of the fourth line was healthy and fertile, yet yielded multiple litters which contained transgenic F1 offspring at Mendelian ratios. These transgenic F1 individuals displayed the same phenotype as the three other independent transgenic mice. This fortunate situation allowed us to study the phenotype of the fourth transgenic line and to confirm the observations using fixed material from the three independent transgenic mice. Transgenic animals were analyzed at P14 when they were still relatively healthy, yet had already replaced their postnatal intervillus pockets by adult-type crypts . Nuclear Ascl2 was observed throughout crypt and villus epithelium (Figures 2A and 2B ). H&E histology revealed dramatic changes in the transgenic epithelium. In the duodenum, villi were branched and displayed crypt-like pockets ( Figures 2C and 2D ). In the ileum, crypts were elongated (''hyperplastic''), while villi were short and disorganized ( Figures 2E and 2F ). Ki67 staining revealed that proliferation in the Ascl2 transgenic intestines occurred in pockets along the villi ( Figures 3A and 3B ) which also expressed the Wnt target gene cMyc ( Figures 3E and 3F ). Ets2, a Wnt target gene specifically expressed at the crypt base (van de Wetering et al., 2002) and enriched in Lgr5 stem cells (Table S1 ) was strongly expressed in the elongated crypts and villi ( Figures 3I and 3J ). The expression domains of the Olfm4 and Lgr5 genes were expanded in the hyperplastic ileal crypts ( Figures 3C, 3D , 3G, and 3H), as was the expression domain of the Sox9 gene ( Figures  3K and 3L ).
In the fly, the achaete-scute gene products form heterodimers with the Daugtherless protein (Cabrera and Alonso, 1991; Caudy et al., 1988) . In a yeast 2-hybrid assay using ASCL2 as bait on a human colon library, we predominantly found the nuclear proteins E22, E2A and HEB as ASCL2-binding partners confirming previous observations (Johnson et al., 1992; Scott et al., 2000) . These three common E-proteins are the homologs of Daughterless. E2a and Heb were expressed in crypts and adenomas ( Figures S2A and S2B ). The crypt-restricted expression of these co-factors explained why the transgenic overexpression of Ascl2 only partially affected the villus epithelium.
Generation of a Conditional Ascl2 Allele As Ascl2
À/À animals die around E10.5 (Guillemot et al., 1994) , we generated a conditional Ascl2 allele ( Figure S3A ). The murine Ascl2 gene contains three exons of which the middle exon encodes the protein. We introduced LoxP sites into 5 0 UTR of exon I and in intron II. Cre-mediated recombination should result in a null allele. The paternal Ascl2 allele is silenced during postimplantation development (Guillemot et al., 1995) . By utilizing the LoxP site in exon I as an allele-specific marker, we found that both alleles of Ascl2 were expressed in the mouse intestine ( Figure S3B ). We crossed the floxed animals with the Ah-Cre mouse in which expression of Cre is driven by the Cyp1a promoter, inducible in a number of tissues by b-Naphtoflavone (ßNF). The resulting gene deletion in the intestinal epithelium is highly efficient, includes the intestinal stem cells and remains stable over many months (Ireland et al., 
2004).
A dramatically different observation was made when we deleted the functionally important c-Myc gene using the same protocol (Muncan et al., 2006) . The epithelium, which was essentially cMyc À/À at day 4 post-induction (PI), was entirely replaced by wild-type epithelium derived from low numbers of escaping, nondeleted cells within 2-3 weeks. We analyzed adult Ah-Cre/Ascl2 floxed/floxed animals at 5, 8, 11 and 15 days PI and compared these to ßNF-treated Ascl2 floxed/floxed litter mates. Intestinal epithelium was subjected to Southern blot analysis ( Figure S3A ). Figure 4A (upper panel) shows recombination of the Ascl2 floxed/floxed locus at the indicated days PI. Complete recombination was observed at the 5-and 8-day time points. At 11 days PI, a partial return of nonrecombined alleles was observed. At day 15, recombined alleles were no longer observed. The rapid reappearance of wild-type epithelium implied a strong selective pressure favoring the few remaining Ascl2 + epithelial Lgr5 stem cells. The Ah-Cre transgene is also inducible in the liver, albeit to a lesser extent . As the Ascl2 gene is not expressed in liver, its deletion should be neutral in terms of selection. A significant, albeit not entirely complete, deletion of the Ascl2 gene was observed in liver ( Figure 4A , lower panel). This deletion pattern remained unchanged over time. Quantitative recombination was confirmed through Northern blot analysis of intestinal epithelial extracts ( Figure 4B ) and Ascl2 antibody stainings ( Figures 4C-4G ).
To directly visualize the rescue process, we bred the Creactivatable Rosa26-LacZ reporter (Soriano, 1999) Figure 4H ). At 10 days PI, nonrecombined epithelial cells started reappearing ( Figure 4I ). At 20 days PI, virtually all crypts were again wild-type ( Figure 4J ). In heterozygous intestines at 20 days PI, the entire epithelium stained blue ( Figure 4K ).
Intestinal Stem Cells Are Lost upon Conditional Deletion of Ascl2
No dramatic histological differences were observed by H&E staining ( Figures 5A and 5B Figures 5C and 5D ). These observations were confirmed by electron microscopy ( Figures S4A and S4B) . There was an increase in apopototic cells in the crypts of floxed animals ( Figures 5E  and 5F ). Analysis at late time points PI revealed a strong increase in crypt fission profiles ( Figures 5G and 5H) . Crypt fission represents a powerful repair mechanism of the intestinal epithelium, for instance after radiation injury or genetic damage (Cairnie and Millen, 1975; Muncan et al., 2006) . To follow the fate of Lgr5 stem cells more precisely, we utilized the robust Olfm4 marker. In situ hybridizations for Olfm4 expression confirmed that the Olfm4 + Lgr5 stem cells were present in every single crypt of control intestines ( Figure 6A ). Five days PI, Olfm4 + Lgr5 stem cells had vanished ( Figure 6B ). At day 8 PI, an Olfm4 signal reappeared in occasional crypts ( Figure 6C ). By 11 days PI ( Figure 6D) control animals at day 3 and 5 days PI. A total of 130 genes, also expressed by Lgr5 stem cells, was significantly downregulated > 1.5-fold at both time points PI. Comparison of these Ascl2 target genes with the stem cell gene signature (Table S1 ) revealed a $25% overlap ( Figure 7A ; Table S2 ).
To identify in vivo ASCL2 binding sites, we performed chromatin immunoprecipitations (ChIP) on human LS174T colorectal cancer (CRC) cells. We probed a customized array containing a set of TCF4-regulated genes (Hatzis and Clevers, unpublished) . Potential ASCL2-bound regulatory regions were verified by qPCR. LGR5, EPHB3 and TNFRSF19 promoters were bound by ASCL2, while the OLFM4 promoter was not. Nonpromoter sequences in the PTPRO, SOAT1, ETS2 and SOX9 loci were also bound by ASCL2 ( Figure 7B) .
As a further validation of these data, we created an LS174T transfectant carrying a stably integrated, doxycycline-inducible sh-RNA expression vector targeting ASCL2. An essentially complete knock-down of the ASCL2 mRNA occurred within 24 hr upon RNAi induction, as shown by Northern blot analysis ( Figure S5A ). We used this cell line to validate the generated ChIP signals. As can be seen in Figure S5B , the ChIP signals for the EPHB3 promoter and the ETS2 enhancer disappeared upon ASCL2 knock-down. We cloned the putative SOX9 enhancer in a luciferase reporter plasmid. Transient transfection was performed in the inducible LS174T ASCL2 RNAi cell line. Figure 7C shows that the spontaneous activity of the SOX9 enhancer was significantly downregulated upon ASCL2 knock-down. For the reverse experiment, we stably integrated a doxinducible ASCL2 expression plasmid into HCT116 cells. This CRC cell line does not express endogenous ASCL2 ( Figure S5C ). Transient transfection of the SOX9 enhancer plasmid in this cell line resulted in a significant activation of the SOX9 enhancer upon ASCL2 induction ( Figure 7D ). We interpreted the combined observations in the following manner. The Ascl2 gene is crucial for the maintenance of Lgr5 stem cells, the only cells in the intestine that express the gene. Part of the stem cell signature is Ascl2-dependent and involves binding of Ascl2 to promoters and/or enhancers elements to activate transcription of these target genes. In the absence of Ascl2 expression, Lgr5 stem cells rapidly disappear. Ascl2 deletion in TA cells does not directly harm these cells as they normally don't express the gene. The mutant TA cells continue to proliferate and provide the villi with differentiated cells. However, no new TA cells are produced from Lgr5 stem cells in mutant crypts. The strong increase in apoptosis in the TA compartment likely mirrors the limited self-renewal capacity that these cells possess. As a consequence, a strong selective pressure is exerted which favors the re-emergence of ''escaper'' crypts harboring intact Ascl2 alleles.
DISCUSSION
Here, we define a minimal gene expression profile for the Lgr5 stem cells. Lgr5 is the most differentially expressed gene within this set. Many other genes in the signature represent previously identified Wnt-dependent genes, e.g., Ascl2, CD44, Ephb3 and Sox9 (van der Flier et al., 2007) . Given the intimate connection between Wnt signaling and the biology of stem cells (Reya and Clevers, 2005) , this was not surprising. At least one novel marker for Lgr5 stem cells, Olfm4, was not expressed under the control of the Wnt pathway, implying the existence of a Wnt-independent specifier for stem cell identity.
Ascl2 is one of the mammalian homologous of the Drosophila achaete-scute complex genes (Johnson et al., 1990) . This complex encodes related bHLH proteins that are powerful regulators of cell fate. The achaete-scute genes are initially expressed in proneural cell clusters were they promote neuroblast differentiation. They are essential for the differentiation of the central as well as peripheral nervous system (Calleja et al., 2002) . Achaete-scute genes are best known as targets of the Notch pathway. Hairy/Enhancer of Split genes, activated by Notch signaling, directly repress the proneural achaete-scute genes. The indirect repression by Notch signals allows achaete-scute gene-expressing cells to be singled-out through lateral inhibition (Simpson, 1990) . However, achaete-scute genes can also be expressed under control of the Wnt pathway. Wingless expression is required for achaete-scute complex gene expression along the wing margin and for achaete-scute-dependent formation of margin bristles and their precursors (Phillips and Whittle, 1993) . Intestinal Ascl2 is expressed under the control of the Wnt pathway. In a recent genome-wide TCF4 Chromatin Immunoprecipitation study, we have observed that the ASCL2 locus in human CRC cells contains two TCF4/b-catenin-bound regulatory elements, indicating that ASCL2 is a direct target of the Wnt pathway (Hatzis et al., 2008) .
Like its fly counterparts, mammalian Ascl2 appears to control lineage specification. In Ascl2-mutant mice, the spongiotrophoblast layer is lost by embryonic day E10 at the expense of trophoblast giant cells (Guillemot et al., 1994; Hughes et al., 2004) . The current study demonstrates that Ascl2 is essential for the maintenance of Lgr5 stem cells in the adult intestinal epithelium and that misexpression of Ascl2 in nonstem cells results in crypt hyperplasia and crypt-like pockets on villi. In conclusion, we have initiated a molecular characterization of the stem cell of the intestinal epithelium by gene expression profiling of essentially pure Lgr5 stem cells. The current study of Ascl2 demonstrates that, with the available genetic tools, the intestinal epithelium constitutes a prime model to unveil molecular mechanisms underlying the biology of stem cells.
EXPERIMENTAL PROCEDURES Isolation of GFP-Positive Epithelial Cells
Freshly isolated small intestines were incised along their length and villi were removed. The intestinal tissue was washed in PBS/EDTA (5 mM) for 5 min, and subsequently incubated in fresh PBS/EDTA for 30 min at 4 C. Vigorous shaking yielded free crypts which were incubated in PBS supplemented with Trypsine (10 mg/ml) and DNase (0.8 u/ml) for 30 min at 37 C. After incubation, cells were spun down, resuspended in SMEM (Invitrogen) and filtered through a 40 mm mesh. GFP-expressing cells were isolated using a MoFlo cell sorter (DAKO). 500 ng of total RNA was labeled using low RNA Input Linear Amp kit (Agilent Technologies, Pato Alto, CA, USA). Labeling, hybridization, and washing protocols were done according to Agilent guidelines. Detailed information is available in Supplemental Experimental Procedures.
Microarray Analysis
Mice
The villin-Ascl2 transgenic expression construct was generated by cloning the mouse Ascl2 coding sequence at the initiation codon of the 9-kb regulatory region of the mouse villin gene (Pinto et al., 1999 ). An SV40 termination and polyadenylation cassette was added downstream ( Figure 2B , insert). Conditional Ascl2 mice were generated through homologous recombination in embryonic stem cells as depicted in Figure ; Sigma Aldrich) dissolved in corn oil.
Isolation of Intestinal Cells for Southern and Northern Blot Analysis
Intestines were cut into small pieces and washed in ice-cold PBS (Mg
). The intestinal pieces were incubated in 30 mM EDTA in PBS at 37 degrees followed by shaking. The released epithelium was then collected to prepare DNA or RNA by standard procedures.
Histology, Immunohistochemistry, and In Situ Hybridization Tissues were fixed in 10% formalin, paraffin embedded, and sectioned. Antibodies: anti-Ki67 (1:100; Novacastra), rabbit anti-c-Myc (1:500; Upstate Biotechnology), mouse anti-Ascl2 (1:5; Supplemental Experimental Procedures), rabbit anti-Sox9 (1:600, Chemicon), rabbit anti-Caspase-3 (1:400; Cell signaling), rabbit anti-GFP (1:6000, gift from E. Cuppen). Peroxidase conjugated secondary antibodies used were Mouse or Rabbit EnVision+ (DAKO). Mouse ESTs were from RZPD. Protocols for in vitro transcription and in situ hybridizations are described elsewhere . b-galactosidase (LacZ) staining was done as described previously (Barker et al., 2007) .
Electron Microscopy Analysis
Tissues were fixed in 2.5% glutaraldehyde + 2.0% paraformaldehyde in cacodylate-buffer, postfixed in 1% OsO4, stained en bloced with uranylacetate, and embedded in Epon resin. The samples were examined with a Phillips CM10 microscope (Eindhoven, The Netherlands).
Generation of Transfected Cell Lines
T-Rex system (Invitrogen) was used to generate a clonal ASCL2-inducible HCT116 cell line as described previously (van de Wetering et al., 2002).
LS174T cells were used to generate a clonal stable, inducible ASCL2 shRNA cell line using the pTER system as described previously (van de Wetering et al., 2003) . Oligonucleotides: Table S3 .
ChIP, qPCR, and Reporter Assays ChIP, qPCR, and Reporter array protocols were performed as described previously (Hatzis et al., 2008) with small modifications. Detailed information is available in Supplemental Experimental Procedures.
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